Life Sciences - Page 29 - Research Triangle Regional Partnership

Triangle therapeutics startup’s deal with global firm RTI is important – here’s why

August 31, 2020

RESEARCH TRIANGLE PARK – A newly established high-powered Research Triangle Park company, APIE Therapeutics, has signed a licensing agreement with …

Durham’s BioCryst lands $44M contract to test anti-viral drug against COVID-19 virus

August 31, 2020

RESEARCH TRIANGLE PARK — BioCryst Pharmaceuticals has landed a $44 million contract to see if its investigational anti-viral drug, galidesivir,…

Bill Gates, Alzheimer’s Association provide $740K grant to RTP startup

August 28, 2020

RESEARCH TRIANGLE PARK – T3D Therapeutics, a life science startup seeking to develop a treatment for Alzheimer’s disease, has another…

RTP-based APIE Therapeutics, RTI team up to develop drug for rare lung disease

August 26, 2020

RESEARCH TRIANGLE PARK — RTI International is teaming up with a local biopharma startup to develop a treatment for a…

As FDA authorizes plasma to combat COVID-19, Clayton plant working on possible treatment

August 24, 2020

CLAYTON – President Donald Trump announced emergency authorization to treat COVID-19 patients with convalescent plasma — a move he called…

Durham life science startup IMMvention shines in LaunchBio Big Pitch competition

August 21, 2020

RESEARCH TRIANGLE PARK – IMMvention Therapeutix almost hit The Big Pitch out of the park. Almost. The 4-year-old Durham company,…

Three NC life science execs crack PharmaVoice ‘most inspiring’ list

August 20, 2020

RESEARCH TRIANGLE PARK – Leading life sciences magazine PharmaVoice has named three North Carolina executives to its list of the…

Triangle’s G1 Therapeutics reaches key milestone in fight against cancer

August 19, 2020

RESEARCH TRIANGLE PARK – G1 Therapeutics, a clinical-stage oncology company based in Research Triangle Park, has reached an important regulatory…

Novavax, partnering with Morrisville firm, lands Covid-19 vaccine deal with U.K.

August 16, 2020

Novavax Inc. has locked in a deal to provide 60 million doses of its Covid-19 vaccine to the United Kingdom,…